|
Dr. Menzaghi has eleven years of drug development and management experience in biotechnology. Her expertise ranges from early exploratory research through clinical development. She has a successful track record in leading drug discovery programs in areas of pain, obesity, psychiatric, cognitive and neurological disorders guiding 4 compounds to Phase 2 clinical trials. Dr. Menzaghi has served as VP Pharmacology and Business Development at Psychogenics Inc. and Director of in vivo Pharmacology at Arena Pharmaceuticals. Prior to that, Dr. Menzaghi established and directed a preclinical research laboratory at SIBIA Neurosciences. She has extensive experience with corporate partnering with large pharmaceutical companies such as Eli Lilly. She has filed 3 INDs and has led successful interdisciplinary teams spanning the entire drug development process. Dr. Menzaghi received her Ph.D. in Neurosciences from the Louis Pasteur University , Strasbourg , France and an MS in clinical psychology from the University of Nancy. She has over 49 peer-reviewed publications and book chapters, 78 international meeting presentations and is listed as an inventor on numerous patents. | 